Agricultural product manufacturers often use terms like biostimulants, beneficial agents, plant boosters, and soil amendments when referring to products created to help plant functioning. While these terms can be similar in a marketing sense, this should not mean that they can be considered the same from a regulatory perspective.
Manufacturers intending to market their products in America must be knowledgeable about product classification, as it can have an impact on their labeling, claims, registration, and market entry. Different states impose different requirements, and certain products may also come under federal jurisdiction based on their ingredients, their intended use, or how the product has been introduced into the country. For instance, the USDA observes that different state departments of agriculture may regulate fertilizers and issue documents for domestic use. However, certain fertilizers intended for import may need additional authorization from federal authorities.
This guide explains how beneficial substances and biostimulants can relate under different U.S. state regulatory frameworks and outlines actions that manufacturers can take before registering their products.
What Is a Biostimulant?
Biostimulants can be generally regarded as products meant to enhance plant processes or any of the following traits, like nutrient utilization, quality of the crop, or plant performance.
Unlike a conventional fertilizer, a biostimulant may not primarily be intended to provide nutrients through a guaranteed analysis. Instead, the product may be marketed based on a particular plant response or function.
However, calling a product a “biostimulant” does not automatically establish its legal classification.
Regulatory authorities may consider factors such as:
- Product formulation
- Ingredients and their concentrations
- Intended use
- Application method
- Label claims
- Guaranteed analysis
- Supporting documentation
- Applicable state definitions and requirements
This means manufacturers should evaluate the complete product profile rather than relying only on the terminology used in marketing materials.
What Are Beneficial Substances?
The term beneficial substance can describe a material intended to provide a benefit to plants, soil, or the growing environment beyond the basic function of supplying conventional nutrients.
The important consideration is that regulatory terminology can differ between jurisdictions. In states that define beneficial substance as a regulatory category, it can function as a broader umbrella that includes different product types, including plant biostimulants.
This means manufacturers should not automatically treat beneficial substances and biostimulants as two separate, mutually exclusive classifications. A product may fall within a state’s beneficial-substance framework while also being evaluated for whether it qualifies to make biostimulant claims.
The exact treatment depends on the applicable state definition, product formulation, intended use, claims, and registration requirements. Manufacturers should therefore distinguish between marketing terminology and regulatory classification.
How Biostimulants Fit Within the Beneficial Substances Framework
The relationship between beneficial substances and biostimulants is clearer when viewed as a regulatory framework rather than a choice between two competing categories.
In states that define “beneficial substance” as the broader category, plant biostimulants can be one type of beneficial substance. The practical question is therefore not simply whether a product is a beneficial substance or a biostimulant, but whether the product falls within the applicable beneficial-substance framework and, if so, whether its formulation and claims meet the requirements for biostimulant treatment or claims.
Nebraska
Nebraska’s Commercial Fertilizer and Beneficial Substances Act expressly includes plant biostimulants within its definition of beneficial substance. This illustrates the umbrella relationship: plant biostimulants can be included within the broader beneficial-substance category.
Vermont
Vermont’s beneficial-substance framework includes plant biostimulants along with plant amendments, plant inoculants, soil amendments, soil inoculants, and other qualifying substances. This means a plant biostimulant can fall within the broader beneficial-substance framework rather than being treated as a separate alternative category.
Minnesota
Minnesota also uses beneficial-substance terminology within its plant-amendment framework and addresses plant biostimulants in that regulatory context. Manufacturers should therefore review how the product fits within Minnesota’s applicable definitions and requirements.
California
California’s revised fertilizer law expressly includes plant biostimulants within the beneficial-substance concept. California also provides guidance addressing plant-biostimulant labeling and claims, making it important to evaluate both the broader product category and the specific claims used on the label and in marketing materials.
A simplified way to understand the relationship in states using this framework is:
Beneficial Substances
→ Plant biostimulants
→ Plant amendments
→ Plant or soil inoculants
→ Soil amendments
→ Other qualifying chemical or biological substances
The exact products and categories included within the beneficial-substance framework depend on the applicable state statutes, regulations, definitions, and registration requirements.
Therefore, manufacturers should ask: “Is this product a beneficial substance under the applicable state framework, and if so, does it also qualify to make biostimulant claims under that umbrella?” rather than assuming they must choose one category over the other.
Do Biostimulants Require State Registration?
There is no single answer that applies to every biostimulant product in every state.
State departments of agriculture can have their own requirements for fertilizers and related agricultural products. USDA specifically notes that state authorities may regulate fertilizers and related products for use within their states.
Whether registration is required can depend on factors such as:
- Product classification
- Ingredients
- Nutrient guarantees
- Intended use
- Label claims
- Distribution plans
- State-specific definitions
- Applicable exemptions
Manufacturers planning to sell in multiple states should therefore evaluate requirements state by state rather than assuming that one registration covers the entire U.S. market.
This assessment is particularly important before commercial distribution because registration, labeling, and renewal requirements may need to be addressed before products are placed on the market.
Why Product Classification Matters
Product classification is one of the most important parts of developing a regulatory strategy.
An incorrect classification can result in:
- Submission under an inappropriate category
- Additional regulatory questions
- Label revisions
- Registration delays
- Additional administrative costs
- Problems during renewals
- Delays in product commercialization
For example, a manufacturer may consider a product a biostimulant because of its intended plant benefit, while a state regulator may evaluate the formulation and claims under another applicable category.
The solution is not to avoid the term “biostimulant.” Instead, manufacturers should understand how the product is treated under the rules applicable to each target market.
How Label Claims Can Affect Registration
Product claims deserve particular attention.
Claims can communicate what a product does, how it works, or what benefit users can expect. Depending on the claim, regulators may evaluate whether the language fits the product’s classification and applicable requirements.
Manufacturers should review claims appearing on:
- Product labels
- Websites
- Technical data sheets
- Brochures
- Product catalogs
- Sales materials
- Advertising content
A claim that appears harmless from a marketing perspective can potentially create regulatory questions if it suggests a function associated with another regulated product category.
A pre-registration label and claims review can therefore help identify potential issues before applications are submitted.
What Should Manufacturers Check Before Registration?
A practical pre-registration review can make the process more organized.
Review the formulation
Compile the complete ingredient information and understand the purpose of each component.
Define the intended use
Clearly establish what the product is designed to do, where it will be used, and how it will be applied.
Review all claims
Evaluate proposed claims across the label and marketing materials, not just the primary product label.
Identify target states
Create a list of states where the product will be manufactured, distributed, or sold.
Determine the applicable category
Assess whether the product falls within the applicable beneficial-substance framework and whether it meets any state-specific requirements for biostimulant claims, fertilizer, soil amendment, or another applicable category.
Review registration requirements
Determine whether registration is required and identify the application, documentation, fees, and supporting information needed.
Check additional federal requirements
Certain products may have federal considerations in addition to state requirements. For example, USDA APHIS regulates certain imported soil amendments and plant-growth enhancers, particularly products containing organic materials or organisms.
Plan for renewals and reporting
Registration should be treated as an ongoing compliance responsibility rather than a one-time submission. Manufacturers should identify applicable renewal dates, fees, reporting obligations, and recordkeeping requirements.
How a Biostimulant Registration Consultant Can Help
Navigating different state requirements can be challenging, particularly for manufacturers preparing to commercialize products across multiple jurisdictions.
A biostimulant registration consultant can help manufacturers evaluate the regulatory pathway before submitting applications. Depending on the product and scope of work, this may include:
- Product classification assessment
- State registration research
- Label and claims review
- Beneficial-substance and biostimulant regulatory assessment
- Registration application support
- Regulatory documentation review
- State submission coordination
- Renewal tracking
- Ongoing compliance support
The value of regulatory consulting is not simply in completing paperwork. A good regulatory strategy helps connect the product formulation, intended claims, labeling, target states, and registration pathway before commercialization.
Why Biostimulant Regulatory Consulting Matters
Businesses benefit most from biostimulant regulatory consulting when they are launching their product across different states or have developed a complex product formulation.
Instead of registering the product separately for every state, manufacturers should develop an overarching registration strategy that aligns with regulatory requirements and takes into account state variations.
Such an approach allows for minimizing redundancy and identifying potential regulatory concerns at the earlier stages of product development.
For manufacturers preparing to enter the U.S. market, Brand Maven Consulting provides regulatory support for agricultural products, including product classification, state registration, labeling, claims, and compliance planning.
Conclusion
The relationship between beneficial substances and biostimulants is not simply a matter of choosing one category over another.
In states that define beneficial substance as a broader regulatory category, plant biostimulants can be included within that framework. Nebraska, Vermont, Minnesota, and California provide examples of U.S. state frameworks where beneficial-substance terminology includes or encompasses plant biostimulants.
The appropriate regulatory treatment can depend on the product’s formulation, ingredients, intended use, claims, and the specific requirements of the state where it will be marketed.
Manufacturers should therefore evaluate whether a product falls within the applicable beneficial-substance framework and, where relevant, whether it meets the requirements for biostimulant claims, rather than assuming that beneficial substance and biostimulant are mutually exclusive classifications.
For businesses getting ready to launch, grow, or enter the U.S. agricultural market, Brand Maven Consulting offers biostimulant regulatory consulting to help with classification, state registration, labeling, claim strategy, renewals, and continued compliance.
A well-planned regulatory strategy can help manufacturers identify requirements earlier, reduce avoidable delays, and create a clearer path toward compliant commercialization.
Frequently Asked Questions
Are biostimulants and beneficial substances separate categories?
Not necessarily. In states that define beneficial substance as a broader regulatory category, plant biostimulants can be included within that framework. The exact treatment depends on the state’s definitions, product formulation, intended use, claims, and applicable requirements.
What should manufacturers determine before making biostimulant claims?
Manufacturers should first determine whether the product falls within the applicable beneficial-substance framework and then assess whether its formulation, intended use, labeling, and claims meet the requirements for biostimulant treatment in the target state.
Does every biostimulant need to be registered?
Not necessarily. Registration requirements depend on the product, its classification, claims, ingredients, and the requirements of the state where it will be sold. A state-by-state assessment is recommended before commercialization.
Can a product registered in one state automatically be sold in another?
Manufacturers need to recognize that obtaining registration in one state does not automatically mean they are registered in another. Each state may have its own registration process, definitions, labeling requirements, fees, and obligations for compliance.
Can label claims affect biostimulant registration?
Yes. Claims can influence how a product is evaluated and whether the proposed label language is consistent with the applicable regulatory category. Claims should therefore be reviewed before finalizing the commercial label.
What information is needed to assess a biostimulant?
The assessment may require formulation and ingredient information, intended use, application method, proposed label, claims, product analysis, target states, and other supporting documentation.
When should manufacturers seek regulatory help?
Ideally, regulatory review should begin before the final label is produced and before commercial distribution begins. Early review can help identify classification, claims, registration, and documentation issues while they are easier to address.
